HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma

SIMPLE SUMMARY: There are several types of uterine cancer. Two of the more rare types are uterine serous carcinoma and carcinosarcoma, which are both very aggressive forms. These rare, aggressive types often have mutations that allow them to be treated with specific therapies that are targeted. One...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Blair, Mutlu, Levent, Greenman, Michelle, Harold, Justin, Santin, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452357/
https://www.ncbi.nlm.nih.gov/pubmed/37627113
http://dx.doi.org/10.3390/cancers15164085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452357/
https://www.ncbi.nlm.nih.gov/pubmed/37627113
http://dx.doi.org/10.3390/cancers15164085

Ejemplares similares